Yeah it's a little tangly.
- It would seem all profit would flow up to the parent entity (unnamed European pharma company), and Enzolytics says the deal gives Enzolytics 50% of "profit derived from sales in the Licensed Territory" without specifying ITV-1 profits only. They left it ambiguous.
- How could Enzolytics have 50% ownership across the board but not 50% revenue sharing across the board?
- If the revenue sharing part of the deal was indeed for ITV-1 revenue only, there would be no revenue since ITV-1 isn't for sale yet.
If instead ENZC would share all profits from this entity, here are some possibilities:
- ENZC should already have been showing revenue and its accounting is bad.
- That parent entity is making zero revenue and thus has none to share.
- That part of the agreement hasn't taken effect yet. ( "Enzolytics will receive $1 Million USD and 50% ownership in the Licensing Entity valued at $8 Million.")
Will be curious to see how it transpires.